Mesoblast Stock Alpha and Beta Analysis
| MESO Stock | USD 11.58 0.53 4.80% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mesoblast. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mesoblast over a specified time horizon. Remember, high Mesoblast's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Mesoblast's market risk premium analysis include:
Beta (0.07) | Alpha 0.97 | Risk 5.14 | Sharpe Ratio 0.18 | Expected Return 0.94 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Mesoblast |
Mesoblast Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mesoblast market risk premium is the additional return an investor will receive from holding Mesoblast long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mesoblast. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mesoblast's performance over market.| α | 0.97 | β | -0.07 |
Mesoblast expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Mesoblast's Buy-and-hold return. Our buy-and-hold chart shows how Mesoblast performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Mesoblast Market Price Analysis
Market price analysis indicators help investors to evaluate how Mesoblast stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mesoblast shares will generate the highest return on investment. By understating and applying Mesoblast stock market price indicators, traders can identify Mesoblast position entry and exit signals to maximize returns.
Mesoblast Return and Market Media
The median price of Mesoblast for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 9.06 with a coefficient of variation of 19.25. The daily time series for the period is distributed with a sample standard deviation of 1.68, arithmetic mean of 8.71, and mean deviation of 1.4. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Mesoblast Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mesoblast or other stocks. Alpha measures the amount that position in Mesoblast has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Mesoblast Upcoming Company Events
As portrayed in its financial statements, the presentation of Mesoblast's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mesoblast's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Mesoblast's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Mesoblast. Please utilize our Beneish M Score to check the likelihood of Mesoblast's management manipulating its earnings.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of September 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Build Portfolio with Mesoblast
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Mesoblast Backtesting, Mesoblast Valuation, Mesoblast Correlation, Mesoblast Hype Analysis, Mesoblast Volatility, Mesoblast History and analyze Mesoblast Performance. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Mesoblast technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.